The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAZ.L Share News (KAZ)

  • There is currently no data for KAZ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Retailers Hit As John Lewis Profit Collapses

Thu, 13th Sep 2018 10:49

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Royal Bank of Scotland, up 1.5%. The state-backed lender could use up to GBP4 billion of extra capital to pay out a special dividends to shareholders, The Times newspaper reported. RBS Chairman Howard Davies told the newspaper that, despite wanting to use the spare cash to buy the bank's shares from the government, if shareholders wanted the special dividend it was a possible option. The special dividend could be up to 33 pence per share to investors, who have not received a payout from the bank in more than 10 years, the newspaper reported. "If there are a lot of shareholders pressing for a special dividend, that is something we would consider," Davies told the Times. ----------Antofagasta, up 0.9%. HSBC raised the Chilean copper miner to Hold from Reduce. ----------FTSE 100 - LOSERS----------Marks & Spencer Group, down 2.7%. Shares in the food, clothing and homewares retailer were lower after department store chain John Lewis Partnership issued a warning for the full-year, amid "challenging times in retail". For the six months to July 28, John Lewis Partnership, which also owns the Waitrose supermarket chain, reported 81% drop in pretax profit to GBP6.0 million from GBP30.8 million a year before. On an adjusted basis, pretax profit slumped 99% to GBP1.2 million. At the end of June, the company had said it expected its interim profit to be "near zero". Looking ahead, John Lewis said that it continues to expect full-year profits to "be substantially lower than last year for the group as a whole". "John Lewis is the bellwether of the UK retail sector, so the fact it's finding life so hard is an indication of just how dire things are on the high street right now," said Hargreaves Lansdown analyst Laith Khalaf. Rival chain Debenhams was down 11%. ----------FTSE 250 - WINNERS----------Grainger, up 5.3%. The residential landlord was raised to Buy from Add by Numis. ----------KAZ Minerals, up 1.8%. HSBC upgraded the Kazakhstan-based miner to Buy from Hold. ----------FTSE 250 - LOSERS----------Inmarsat, down 2.0%, Equiniti Group, down 1.8%. The stocks went ex-dividend meaning new buyers no longer qualify for the latest dividend payout. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Bushveld Minerals, up 18%. The miner said it has raised its interest in the Vametco vanadium mine located near Pretoria, South Africa, to 75% from 59.1%. Bushveld has acquired the entire 21.22% interest that Sojitz Noble Alloys Corp held in Strategic Minerals Corp, the 75% owner of Vametco, for USD20 million in cash. Following completion of the deal, Bushveld via its Bushveld Vametco unit will own 100% of Strategic Minerals Corp and therefore have an indirect beneficial interest of 75% in the Vametco mine. The company used its existing cash resources to complete the stake acquisition.----------OTHER MAIN MARKET AND AIM - LOSERS----------Faron Pharmaceuticals, down 15%. The biopharmaceutical company said its loss for the first half of its financial year increased on higher research costs. For the six months to June 30, the firm posted pretax loss of EUR14.1 million compared to EUR7.1 million a year prior on increased research & development costs by 95% year-on-year to EUR11.7 million from EUR6.0 million. Administrative expenses also increased to EUR2.4 million from EUR1.5 million. As the company focuses on developing drugs, it only generated revenue of EUR20,000 from product sales to Maruishi Pharmaceutical. A year ago revenue was nil. Research expenses increased as a result of clinical costs associated with an unsuccessful trial of Traumakine, a treatment for acute respiratory distress syndrome, as well as an increase in development activities for Clevegen, a potential treatment for various types of cancer, the company explained.----------
More News
5 May 2021 15:54

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
4 May 2021 15:37

IN BRIEF: Takeover vehicle of Kaz Minerals chair to buy rest of shares

IN BRIEF: Takeover vehicle of Kaz Minerals chair to buy rest of shares

Read more
29 Apr 2021 11:03

Kaz Minerals on track for annual guidance amid metals production drop

Kaz Minerals on track for annual guidance amid metals production drop

Read more
26 Apr 2021 07:38

Bidco Nova Resources moves to take Kaz Minerals private

April 26 (Reuters) - The consortium bidding to take KAZ Minerals private said on Monday its bid for the copper miner had been declared unconditional after winning more than 90% of support.Nova Resources, led by KAZ Minerals Chairman Oleg Novachuk ...

Read more
9 Apr 2021 17:44

IN BRIEF: Kaz Minerals takeover by Nova becomes unconditional

IN BRIEF: Kaz Minerals takeover by Nova becomes unconditional

Read more
7 Apr 2021 09:42

BROKER RATINGS: Barclays cuts Kaz to equal weight from overweight

BROKER RATINGS: Barclays cuts Kaz to equal weight from overweight

Read more
7 Apr 2021 08:07

LONDON BRIEFING: Downbeat Ryanair says financial 2022 to be breakeven

LONDON BRIEFING: Downbeat Ryanair says financial 2022 to be breakeven

Read more
6 Apr 2021 08:41

Kaz Minerals confirms special tax status for Russian copper project

Kaz Minerals confirms special tax status for Russian copper project

Read more
26 Mar 2021 09:43

BROKER RATINGS: Jefferies upgrades Imperial Brands and downgrades BAT

BROKER RATINGS: Jefferies upgrades Imperial Brands and downgrades BAT

Read more
26 Mar 2021 09:34

Kaz Minerals chair raises takeover offer to more than GBP4 billion

Kaz Minerals chair raises takeover offer to more than GBP4 billion

Read more
26 Mar 2021 09:31

UPDATE 2-European stocks close to all-time highs as miners, tech shine

* Miners, tech boost STOXX 600* Benchmark index 7 points short of record highs* Maersk rebounds after sharp losses on Suez Canal blockage* ABB gains on $4.3 bln share buyback plan (Updates to close, adds fresh comments)By Sruthi ShankarMarch 26 (Reu...

Read more
26 Mar 2021 09:28

UPDATE 2-FTSE 100 logs strongest day in over two weeks on commodity-linked boost

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Miners biggest gainers on FTSE 100* UK retail sales rise 2.1% in February* Smiths Group tops index on upbeat forecast* Both FTSE 100 and FT...

Read more
26 Mar 2021 08:38

UPDATE 1-Buyout group makes $5.5 bln final bid for KAZ Minerals

(Adds details, share price)March 26 (Reuters) - A consortium aiming to take copper miner KAZ Minerals private has increased its bid by 9% to 4.02 billion pounds ($5.5 billion) after minority shareholders indicated they would reject earlier proposa...

Read more
26 Mar 2021 08:38

UPDATE 2-Buyout group makes $5.5 bln final bid for KAZ Minerals

(Adds minority shareholder's view)March 26 (Reuters) - A consortium aiming to take copper miner KAZ Minerals private has increased its bid by 9% to 4.02 billion pounds ($5.5 billion) after minority shareholders indicated they would reject earlier ...

Read more
26 Mar 2021 08:22

LONDON BRIEFING: Aviva completes streamlining push with sale in Poland

LONDON BRIEFING: Aviva completes streamlining push with sale in Poland

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.